A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck

Oral Oncology ◽  
2015 ◽  
Vol 51 (3) ◽  
pp. 279-286 ◽  
Author(s):  
Vijay Maruti Patil ◽  
Vanita Noronha ◽  
Amit Joshi ◽  
Vamshi Krishna Muddu ◽  
Sachin Dhumal ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Single Agent ◽  
Metronomic Chemotherapy ◽  
Randomized Phase Ii

scholarly journals A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

2014 ◽  
Vol 25 (9) ◽  
pp. 1813-1820 ◽  
Author(s):  
T.Y. Seiwert ◽  
J. Fayette ◽  
D. Cupissol ◽  
J.M. del Campo ◽  
P.M. Clement ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Recurrent Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document